bioMérieux Revenue

In the year 2024, bioMérieux had annual revenue of 3.98B EUR with 8.31% growth. bioMérieux had revenue of 2.08B in the half year ending December 31, 2024, with 7.61% growth.

Revenue

3.98B EUR

Revenue Growth

+8.31%

P/S Ratio

3.69

Revenue / Employee

269.75K EUR

Employees

14,754

Market Cap

15.22B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.98B	305.20M	8.31%
Dec 31, 2023	3.67B	85.60M	2.39%
Dec 31, 2022	3.59B	212.90M	6.31%
Dec 31, 2021	3.38B	258.00M	8.27%
Dec 31, 2020	3.12B	443.40M	16.58%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
SS Innovations International	20.65M
Veradigm	588.02M
Northwest Biotherapeutics	1.38M
Elite Pharmaceuticals	70.00M
Glass House Brands	200.90M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings

bioMérieux News

6 weeks ago - bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
8 months ago - bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha
3 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
4 years ago - bioMérieux: Pioneering In Vitro Diagnostics - Seeking Alpha
4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha

More News